GSK today announced that Phil Dormitzer M.D., Ph.D., will join the company as Global Head of Vaccines R&D on 3 December 2021. Phil will report to Dr Hal Barron, Chief Scientific Officer… Read More
The first peer-reviewed study in North America examining dosing intervals for COVID-19 mRNA vaccines shows a delayed second dose leads to a stronger immune response. CHÉOS Scientist and principal investigator… Read More
The first peer-reviewed study in North America examining dosing intervals for COVID-19 mRNA vaccines shows a delayed second dose leads to a stronger immune response. CHÉOS Scientist and principal investigator… Read More
50/50 joint venture with investor syndicate led by Frazier Healthcare Partners and Pivotal bioVenture Partners China Expands global reach and execution for Chinook’s atrasentan and BION-1301 programs in IgA nephropathy (IgAN) SEATTLE… Read More
Apply to be part of this special Trade Accelerator Program (TAP) in partnership with the Canadian Council for Aboriginal Business (CCAB), specifically designed for Indigenous-owned/led businesses. TAP is designed to… Read More
